Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Lenz Therapeutics, Inc.”

6 pharma patents match "Lenz Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Lenz Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Lenz Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11648247

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted

  2. US 11344538

    Methods for the treatment of myopia

    Lenz Therapeutics, Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted

  3. US 11273150

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  4. US 11214569

    Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof

    Lenz Therapeutics, Inc. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  5. US 11179328

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  6. US 11179327

    Compositions and methods for the treatment of presbyopia

    Lenz Therapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.